• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒功能障碍与血液系统疾病。

Telomere dysfunction and hematologic disorders.

作者信息

Paiva Raquel M A, Calado Rodrigo T

机构信息

Department of Internal Medicine, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, São Paulo, Brazil.

出版信息

Prog Mol Biol Transl Sci. 2014;125:133-57. doi: 10.1016/B978-0-12-397898-1.00006-2.

DOI:10.1016/B978-0-12-397898-1.00006-2
PMID:24993701
Abstract

Aplastic anemia is a disease in which the hematopoietic stem cell fails to adequately produce peripheral blood cells, causing pancytopenia. In some cases of acquired aplastic anemia and in inherited type of aplastic anemia, dyskeratosis congenita, telomere biology gene mutations and telomere shortening are etiologic. Telomere erosion hampers the ability of hematopoietic stem and progenitor cells to adequately replicate, clinically resulting in bone marrow failure. Additionally, telomerase mutations and short telomeres are genetic risk factors for the development of some hematologic cancers, including myelodysplastic syndrome, acute myeloid leukemia, and chronic lymphocytic leukemia.

摘要

再生障碍性贫血是一种造血干细胞无法充分产生外周血细胞而导致全血细胞减少的疾病。在某些获得性再生障碍性贫血病例以及遗传性再生障碍性贫血、先天性角化不良、端粒生物学基因突变和端粒缩短的情况下,它们是病因。端粒侵蚀会妨碍造血干细胞和祖细胞充分复制的能力,临床上会导致骨髓衰竭。此外,端粒酶突变和短端粒是包括骨髓增生异常综合征、急性髓系白血病和慢性淋巴细胞白血病在内的一些血液系统癌症发生发展的遗传风险因素。

相似文献

1
Telomere dysfunction and hematologic disorders.端粒功能障碍与血液系统疾病。
Prog Mol Biol Transl Sci. 2014;125:133-57. doi: 10.1016/B978-0-12-397898-1.00006-2.
2
Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.先天性和获得性再生障碍性贫血患者的端粒长度变异及端粒酶活性表达
Acta Haematol. 2004;111(3):125-31. doi: 10.1159/000076519.
3
Telomerase and telomere biology in hematological diseases: A new therapeutic target.血液系统疾病中的端粒酶与端粒生物学:一个新的治疗靶点。
Leuk Res. 2017 May;56:60-74. doi: 10.1016/j.leukres.2017.02.002. Epub 2017 Feb 7.
4
Telomeres and marrow failure.端粒与骨髓衰竭。
Hematology Am Soc Hematol Educ Program. 2009:338-43. doi: 10.1182/asheducation-2009.1.338.
5
Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.端粒酶基因治疗可挽救再生障碍性贫血小鼠的端粒长度、骨髓再生不良和生存。
Blood. 2016 Apr 7;127(14):1770-9. doi: 10.1182/blood-2015-08-667485. Epub 2016 Feb 22.
6
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.先天性角化不良症及相关端粒生物学疾病的生物学和治疗进展。
Expert Rev Hematol. 2013 Jun;6(3):327-37. doi: 10.1586/ehm.13.23.
7
Telomeres, telomerase, and hematopoietic stem cell biology.端粒、端粒酶与造血干细胞生物学
Arch Med Res. 2003 Nov-Dec;34(6):489-95. doi: 10.1016/j.arcmed.2003.07.003.
8
The role of telomere biology in bone marrow failure and other disorders.端粒生物学在骨髓衰竭及其他病症中的作用。
Mech Ageing Dev. 2008 Jan-Feb;129(1-2):35-47. doi: 10.1016/j.mad.2007.11.002. Epub 2007 Nov 19.
9
Bone marrow failure and the new telomere diseases: practice and research.骨髓衰竭与新型端粒疾病:实践与研究
Hematology. 2012 Apr;17 Suppl 1:S18-21. doi: 10.1179/102453312X13336169155132.
10
Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.简明综述:正常及白血病造血干细胞中的端粒生物学
Stem Cells. 2007 Aug;25(8):1853-61. doi: 10.1634/stemcells.2007-0057. Epub 2007 May 17.

引用本文的文献

1
The Telomere Length Signature in Leukemias-From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase.白血病中的端粒长度特征——从端粒缩短的分子机制到针对端粒酶的免疫治疗选择
Cancers (Basel). 2025 Jun 10;17(12):1936. doi: 10.3390/cancers17121936.
2
Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases.基于诱导多能干细胞的再生疗法治疗人类衰老相关功能衰退和疾病
Cells. 2025 Apr 21;14(8):619. doi: 10.3390/cells14080619.
3
Telomerase () Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.
端粒酶()过表达揭示了不同临床亚型小儿急性淋巴细胞白血病有希望的预后生物标志物和治疗靶点。
Genes (Basel). 2021 Oct 17;12(10):1632. doi: 10.3390/genes12101632.
4
Telomere Length and Hematological Disorders: A Review.端粒长度与血液系统疾病:综述
In Vivo. 2020 Nov-Dec;34(6):3093-3101. doi: 10.21873/invivo.12142.
5
Is the telomere length associated with neurocognitive disabilities in HIV-1-infected subjects?端粒长度与HIV-1感染受试者的神经认知障碍有关吗?
Rev Inst Med Trop Sao Paulo. 2018;60:e16. doi: 10.1590/s1678-9946201860016. Epub 2018 Apr 23.
6
Heterozygous variants in bone marrow failure and myeloid neoplasms.骨髓衰竭和髓系肿瘤中的杂合性变异。
Blood Adv. 2018 Jan 4;2(1):36-48. doi: 10.1182/bloodadvances.2017008110. eCollection 2018 Jan 9.